CD8 T Cells Can Reject Major Histocompatibility Complex Class I-Deficient Skin Allografts
Open Access
- 1 May 2004
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 4 (5), 698-704
- https://doi.org/10.1111/j.1600-6143.2004.00416.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cross-primed CD8+ T cells mediate graft rejection via a distinct effector pathwayNature Immunology, 2002
- Effector and memory T-cell differentiation: implications for vaccine developmentNature Reviews Immunology, 2002
- Preferential Localization of Effector Memory Cells in Nonlymphoid TissueScience, 2001
- Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosisThe Journal of Heart and Lung Transplantation, 2000
- Transporters Associated with Antigen Processing (TAP)-independent Presentation of Soluble Insulin to α/β T Cells by the Class Ib Gene Product, Qa-1bThe Journal of Experimental Medicine, 1998
- ANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEXAnnual Review of Immunology, 1996
- Antigen presentation to cytotoxic T lymphocytes in vivo.The Journal of Experimental Medicine, 1995
- Self-restricted primary human histocompatibility leukocyte antigen (HLA)-specific cytotoxic T lymphocytesInternational Immunology, 1993
- A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules.The Journal of Experimental Medicine, 1991
- Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.The Journal of Experimental Medicine, 1990